We generated human iPS derived neural stem cells and differentiated cells from healthy control individuals and an individual with autism spectrum disorder carrying bi-allelic NRXN1-alpha deletion. We investigated the expression of NRXN1-alpha during neural induction and neural differentiation and observed a pivotal role for NRXN1-alpha during early neural induction and neuronal differentiation. Single cell RNA-seq pinpointed neural stem cells carrying NRXN1-alpha deletion shifting towards radial glia-like cell identity and revealed higher proportion of differentiated astroglia. Furthermore, neuronal cells carrying NRXN1-alpha deletion were identified as immature by single cell RNA-seq analysis, displayed significant depression in calcium signaling activity and presented impaired maturation action potential profile in neurons investigated with electrophysiology. Our observations propose NRXN1-alpha plays an important role for the efficient establishment of neural stem cells, in neuronal differentiation and in maturation of functional excitatory neuronal cells.
Introduction
Autism spectrum disorders (ASD) are a set of heterogeneous neurodevelopmental conditions that affect~1% of worldwide population [1] with important personal, familial, economic, and societal burdens [2] . Symptoms include impairments in social interaction and communication, with accompanying restricted or repetitive behaviors, activities, or obsessive interests [3] . ASD has strong and complex genetic architecture with more than 100 associated loci or chromosomal abnormalities [4] . Among them, multiple genes in the neurexin family are known to be involved in ASD [5] and schizophrenia [6] . Neurexins have been studied specifically in synapse formation and synaptic plasticity during neural development. They are cell adhesion molecules in the presynaptic cell membrane in both excitatory and inhibitory synapses and play an important role in calcium-dependent transmission in the central and peripheral nervous system (for review see Ref. [7] ). Neurexin 1 (NRXN1) is transcribed from multiple different promoters, but has two predominant isoforms, the longer NRXN1-alpha (NRXN1-a) and shorter C-terminal NRXN1beta (NRXN1-b) [8, 9] . NRXN1-a isoforms preferentially bind to a variety of trans-synaptic partners, including neuroligins, cerebellins, neurexophilins, and leucine-rich repeat transmembrane proteins each of which serve different synaptic functions [7, 10] .
Rare copy number variants impacting combinations of exons in NRXN1-a have been associated with ASD and schizophrenia [11] and appears to exert an impact on disease phenotype [6, 10] . Several studies have developed animal and cellular models to acquire an in-depth perspective on NRXN1-a functionality and co-interactors. Mouse studies https://doi.org/10.1016/j.yexcr.2019.06.014 Received 20 May 2019; Received in revised form 31 May 2019; Accepted 11 June 2019 revealed deletion of pan-neurexin-alphas (Nrxn1-a, Nrxn2-a, Nrxn3-a) impaired both spontaneous and evoked Ca 2+ triggered neurotransmitter release in excitatory and inhibitory synapses in the brainstem and neocortex [12] . Further, Nrxn1-a deficient mice have impaired excitatory synaptic transmission in the hippocampus but no significant alterations in social behaviors or in spatial learning [13] .
Additionally, mice with pan-neurexin deletion maintain normal synapses numbers but show a massive impairment in action potentialinduced calcium influx in neurons [14] . Moreover, comparison of Nrxn1-a double-knockout mice and human cellular models established by introducing heterozygous mutation into NRXN1-a revealed that hetero-or homozygous mutation of murine Nrxn1-a have no significant effects on functional characteristics of cortical neurons while heterozygous mutation of human NRXN1-a impairs neurotransmitter release and frequency of spontaneous evoked excitatory postsynaptic currents in embryonic stem cell-derived induced neurons [5] . These studies indicated the importance of NRXN1-a in human development, cognition and intellectual activities and also highlighted the need for a specific cell model with complete absence of NRXN1-a to identify its impact and also its potential partners in human neurogenesis.
Here, we took advantage of iPS cell technology [15, 16] to generate a iPS cell model from an individual with autism spectrum disorder carrying bi-allelic NRXN1-a deletion (del) [17] . From these iPS cells we derived neuroepithelial stem (NES) cells and performed single cell RNA sequencing [18] to shed light on gene expression patterns affected by NRXN1-a del during neuronal differentiation.
Results

Cellular model of early and late neuronal development display two waves of NRXN1 expression
iPS cells from an individual diagnosed with ASD carrying bi-allelic NRXN1-a del [17] and healthy control individuals (Ctrl-7, Ctrl-3, Ctrl-9, Ctrl-10) [19] [20] [21] were generated from skin fibroblasts, induced toward neuroepithelial stem (NES) cells [22] and further spontaneously differentiated to neurons for 28 days (DIFF), 49 days and 70-75 days ( Fig. 1A ). Established iPS cells were characterized pluripotent by morphology, positively stained for OCT4 and NANOG, microarray transcriptomes were probed for pluripotency markers, analyzed by Pluritest [23] and the iPS cell lines showed stable karyotype (Figs. S1A-S1E, for Ctrl-7, Ctrl-9, Ctrl-10, Ctrl-3 see Refs. [19] [20] [21] )).
Healthy control NES and NRXN1-a del NES cells were established with a modified dual SMAD inhibition protocol [24] . During neural induction we observed a complete absence of NRXN1-a expression in NRXN1-a del iPS cells, while in the same time interval NRXN1-a doubled in healthy control cells at day 2 and gradually decreased until day 12 at capture of NES cells (Fig. 1B) . We also observed this pattern of NRXN1 expression peaking during neural induction in Cortecon (http://cortecon.neuralsci.org) [25] (Fig. S1F ). Additionally, when we probed single cell RNA-seq data of human preimplantation embryo [26] we also noticed NRXN1 expressed during early embryonic development ( Fig. S1G ). These combined observations suggest NRXN1-a possessing a developmentally earlier function rather than only acting in the synapse.
Despite differences of NRXN1 expression in healthy control cells and NRXN1-a del cells during neural induction, established NES cells from both healthy individuals and NRXN1-a del individual appeared growing in organized rosette-like morphology with apical distribution of the cell surface marker ZO1. The NES cells stained positive for broad neural stem cell markers such as NESTIN, SOX2, PLZF and furthermore, we did not detect significant differences in spontaneous calcium signaling activity ( Fig. 1C, Fig. S1H, Fig. S1I ). These combined observations suggested we had established stable NES cell lines.
To our surprise, when measuring newly synthesized DNA by incorporation of EdU to assess cell cycle phases, we observed a significant higher percentage of EdU negative NRXN1-a del NES cells in G0/G1-phase, indicating a slower proliferation rate than Ctrl-7 NES, while simultaneously observing a significant higher percentage of EdU positive Ctrl-7 NES cells in G2 phase. (Fig. 1D) . Similarly, when we counted cells for proliferation marker Ki-67, higher proportions were observed in Ctrl-7 NES cells thus indicating a slower proliferation rate in NRXN1-a del NES cells ( Fig. S1J ). These differences in proliferation suggested to us that cell identity in NRXN1-a del NES cells might be altered.
Probing for NRXN1-a expression in healthy NES cells undergoing differentiation by growth factor removal, we detected a ramping up of expression from nearly no levels to robust upregulation upon 28 days of differentiation. Meanwhile as expected, we neither detected mRNA or protein of NRXN1-a in NRXN1-a del DIFF cells ( Fig. 1E and F) . Curiously, we did not observe obvious neuronal differentiation differences between Ctrl-7 DIFF and NRXN1-a del DIFF morphology (Fig. 1G ). These superficial observations lead us to consider neuronal differentiation also functions under other compensatory mechanisms not entirely dependent on presence of NRXN1-a expression in the neurons.
To investigate whether NRXN1-a expression during early neuronal development influences neuronal differentiation, we took a transcriptomics approach [18] and obtained Single cell RNA-seq from 984 high quality single cells that were used for analysis at the NES cell stage and DIFF cell stage ( Fig. 1A schematic single cells). In our single cell data we verified high NRXN1 expression in Ctrl-7 DIFF single cells and low expression of NRXN1 in NRXN1-a del DIFF single cells ( Fig. 1H ). Thus reflecting our observations in the bulk sample qPCR. Similarly, when looking at genes related to proliferation, we observed fewer NRNX1-a del NES cells compared to Ctrl-7 NES cells ( Fig. 1I ). In single cell transcripts mapped to the genomic region of NRXN1, again we confirmed NRXN1-a long transcript expression in Ctrl-7 DIFF cells and exclusive expression of NRXN1-b short transcript in NRXN1-a del DIFF cells ( Fig. S1K ). These combined observations strongly indicate a complete absence of NRXN1-a in NRXN1-a del cells.
Our unexpected observations of NRXN1 expression during developmentally early time points agree with recent studies showing similar NRXN1 expression patterns in various types of radial glia cells and neuronal cell types of human fetal brain during embryonic development (http://linnarssonlab.org/ventralmidbrain/and https://bitly.com/ cortexSingleCell) [27, 28] . In addition, slower proliferation rate has previous been reported to be indicative of shifting identity in fetal neural stem cells [29, 30] .
NRXN1-a deletion alters outcome of cell identity in established NES and DIFF cells
We used BackSPIN [31] , a bi-clustering algorithm on single cells for both Ctrl-7 and NRXN1-a del NES and DIFF to identify the 2000 most variable genes across 984 single cell transcriptomes to identify cell types present in our single cell RNA-seq experiment (Table S1 ). As expected, we observed that both NES and DIFF cells consisted of various cell types appearing during early and late neurogenesis. Four cell types were identified among NES cells: neural stem cells, radial glia-like cells, intermediate progenitors (IP) for neurons and IP for astroglia. In DIFF cells we identified another four cell types namely immature neurons, immature astroglia, neurons and astroglia ( Fig. 2A ), these cells appeared in line with expected outcome of differentiation [32] .
We visualized the identified cell types in tSNE plot [33] and observed reasonable separation ranging from NES to DIFF cells with little overlap (Fig. 2B ). Further, we observed sample conditions separating Ctrl-7 and NRXN1-a del cells ( Fig. 2C ). Looking into the NES and DIFF cell contribution in cell types, we found significant differences (χ 2 = 1283.4, df = 21, p-value < 2.2e-16) with Ctrl-7 cells consisting mostly of neural stem cells, intermediate progenitors and neurons. In contrast to cell types representing Ctrl-7 cells, NRXN1-a del cells consisted of radial glia-like cells, immature neurons and astroglia ( Fig. 2D ). We found highly enriched genes in each cell type, GJA1, HIST1H3C, WNT4 in neural stem cells, MAGEL2, SNCG, CDKN1A in IP for neurons, CNTN2, DLL3, NEUROG1 in immature neurons and MYT1L, NRXN1, RTN1 in neurons ( Fig. 2E-H) . Similarly, we found PAX6, HES5, SOX3 in radial glia-like cells, AQP4, CALB1, NPY in IP for astroglia, CLU, ENKUR, SLIT3 in immature astroglia and APOE, CD44, TNC in astroglia ( Fig. 2I-L ). Comparing genes in our identified cell types to fetal brain cells during development [27, 28] we saw NES cells expressing GJA1, HIST1H3C, CNTN2, NEUROG1, NRXN1 and MYT1L reaffirmed neuronal fate choice while radial glia-like cells expressing HES5, PAX6, SOX3, APOE, CD44 and TNC reaffirmed astroglia (non-neuronal) fate choice (Figs. S2A and S2B). Taken together, these observations indicated NRXN1-a deletion affects establishment of NES cells, since we observed skewed cell type distribution between Ctrl-7 and NRXN1-a del cells in the outcome of established neural progenitors, intermediate progenitors, differentiating neuronal cells and non-neuronal cells.
Pseudotime and trajectory modeling reveal NRXN1-a deletion results in higher proportion of astroglia in differentiated cells
Recognizing the inherent character of unsynchronized non-directed differentiation in our NES cell differentiation protocol, we used Monocle 2 [34] to order single cells in pseudotime. Pseudotime and trajectory projection placed all NES and DIFF cells along a differentiation trajectory starting from neural stem cells and ending in differentiated cells (Fig. 3A) . We observed during differentiation cells choose two distinctly different fates and differentiated either into neurons or astroglia (Fig. 3B, S3A and Table 2 ).
When we plotted trajectory according to sample conditions, distinct patterns of distribution emerged along the projected trajectory between the Ctrl-7 DIFF and NRXN1-a del DIFF cells. Ctrl-7 DIFF cells aggregated into the neuron branch while NRXN1-a del DIFF cells spread out across all three branches ( Fig. 3C ). Hence, our observation suggests healthy control DIFF cells mainly differentiate into neurons while approximately half of NRXN1-a del DIFF cells differentiate towards neurons and remaining cells differentiate towards astroglia. (Fig. S3B ). Estimating the proportion of cell fate commitment, we plotted identified cell types onto pseudotime trajectory backbone and observed at each stage of the differentiation process differences between control cells and NRXN1-a del cells. We observed how individual's contributed to cell types and observed neural stem cell contained mostly Ctrl-7 NES cells with a small fraction of NRXN1-a del NES cells, while radial gliallike cells contained mostly NRXN1-a del NES cells with a small fraction of NRXN1-a del DIFF cells. Further, we saw IP for neurons were equally distributed between individuals while IP for astroglia had more Ctrl-7 NES cells and immature cells had higher proportion originating from NRXN1-a del cells. Finally, we saw that Ctrl-7 DIFF contributed to neuronal cells and NRXN1-a del DIFF contributed to astroglia/nonneuronal cells (Fig. 3D) .
Looking at individual genes differentially expressed over pseudotime and branches, we observed robust enrichment of neuronal genes (e.g DCX, NCAM1, ROBO3, SYT4) in the neuron branch and non-neuronal genes (e.g APOE, COL6A3, MGP, PDGFRB) in the astroglia branch ( Fig. 3E and F). To validate our single cell observation we used Western blot and immunocytochemistry to probe for neuronal markers B3-tubulin and astroglial markers S100B, GFAP and FABP7 in our healthy control lines, and two additional NRXN1-a del NES clone cell lines and detected higher levels of astroglial related protein expression in differentiated NRXN1-a del cells at 28 days of differentiation ( Fig. 3G and Fig. S3C ).
Altogether our observations indicate that control NES cells at 28 days without growth factors predominantly differentiate towards neuronal cells (~90%) and lesser extent non-neuronal cells (~10%) while NRXN1-a del NES cells differentiate towards neuronal (~50%) and nonneuronal cells (~50%) adding up that NRXN1-a indeed plays a significant role in NES cell differentiation.
NRXN1-a deletion affects neuronal maturation and impairs emergence of excitatory neurons
We were further interested in studying the neuronal differentiation in Ctrl-7 and NRXN1-a del DIFF cells and looked into subset of immature neurons and neurons identified by BackSPIN (Fig. 4A ). In the neuronal subtypes, we identified differentially expressed genes over three branches (Fig. S4A , Table S3 ) separating immature neurons and neuronal subtypes into inhibitory and excitatory neurons (Fig. 4B ). We employed pseudotime ordering to estimate neuronal maturation and observed bifurcation point along the trajectory root branch coinciding with separation of neuronal subtypes ( Fig. 4C and D) . We selected genes for visualization of enrichment along the branches and displayed genes for immature (e.g. FABP7, HES6, NEUROG1), inhibitory (e.g. CNTN2, GABRG1, GAD1) and excitatory neurons (e.g. CHRNA2, GRM5, RBFOX1) ( Fig. 4E ). Separately plotting trajectories for Ctrl-7 and NRXN1-a del cells, we noted distribution differences in neuronal subtypes (Fig. 4F panel) and counting cells assigned to branches we observed Ctrl-7 cells consisting of 16% immature neurons, 35% inhibitory neurons and 49% excitatory neurons while NRXN1-a del cells consisted of 56% immature neurons, 33% inhibitory neurons and 11% excitatory neurons (Fig. 4G panel) . These observed differences in neuronal subtype distribution suggested NRXN1-a del neurons being vastly different to the healthy control neurons at 28 days of differentiation.
Following up on observations in single cells, we validated immature neuronal identity in bulk differentiation samples with qPCR Taqman array against a panel of neurotransmitters. Here, we observed significant decrease in mRNA expression in NRXN1-a del DIFF cells when compared to healthy control DIFF cells (Fig. S4H) .
These observations further led us to test functionality by calcium signaling and electrophysiological property. We considered NRXN1 previously described as a presynaptic protein playing an essential role in synaptic transmission and voltage gated calcium channels play a major role in synaptic vesicle release [12] . We interrogated calcium signaling and recorded clear differences in calcium concentration [Ca 2+ ] i responses to depolarizing concentrations of KCl between Ctrl-7 and NRXN1-a del cells at both 28 days and 49 days of differentiation, Fig. 1 . Establishment of neural stem cells and neuronal differentiation display NRXN1-a expressed twice during development. A) Experimental overview, iPS cells and NES cells established from individuals, samples from neural stem cells and differentiated cells collected for single cell RNA-seq. B) NRXN1-a gene expression during neural induction, NRXN1-a expression in three control iPS cells (Ctrl-7, Ctrl-9 and Ctrl-10) peak around day 2 and gradually decrease until NES cells are established, NRXN1-a is completely absent in NRXN1-a del iPS cells during neural induction. * Significant difference to iPS cells with p-value ≤0.05. C) NES cell morphology displayed in brightfield and immunocytochemistry staining for neural stem cell markers in ZO1, NESTIN, SOX2 and PLZF for Ctrl-7 and NRXN1-a del NES cells. No obvious differences observed between individuals, scalebar: 50 μm. D) EdU incorporation assay quantified by FACS representative images, 10.000 events were recorded (n = 3), barplot shows NRXN1-a del NES cells have lower EdU incorporation and more cells in G0/G1 phase (p-value < 0.001) while control NES cells (Ctrl-7 and Ctrl-10 (data not shown)) have higher EdU incorporation and more cells in G2 phase (p-value < 0.05) indicating lower proliferation rate in NRXN1-a del NES cells. E) NRXN1-a gene expression during neural differentiation for 28 days, three control NES lines (Ctrl-7, Ctrl-9 and Ctrl-10) DIFF cells gradually expresses higher levels of NRXN1-a while NRXN1-a del DIFF do not. N = 3. * P-Value≤0.05. ** P-Value≤0.001. F) NRXN1-a protein probe with Western blot during 28 days of differentiation (NES cells, Day 7, Day 14 and Day 28), NRXN1-a detected in Ctrl-7 DIFF cells while no protein is seen in NRXN1-a del DIFF cells. G) Beta-3 tubulin immunocytochemistry staining in Ctrl-7 DIFF cells and NRXN1-a del DIFF cells showed no obvious differences, scalebar: 50 μm. H) NRXN1 expression in 984 single cells, observation of NRXN1 expressed in Ctrl-7 DIFF cells and NRXN1-a del DIFF cells. I) Barplots for presence of proliferation markers (MKI67, PCNA, CDK1, GMNN, TOP2A) in single cell transcriptomes display more expression in Ctrl-7 NES cells compared to NRXN1-a del NES cells. here NRXN1-a del cells had significantly lower amplitude and slower rise time (Fig. 4H, I and 4J ). Next, we investigated electrophysiological properties and patched responsive neurons at 70-75 days of differentiation. Here, we disentangled neuron maturation stages by significant differences in action potential amplitude (APA) for both Ctrl-7 neurons and NRXN1-a del neurons. We classified maturation stages by immature (APA below 95 mV), intermediate mature (APA between 95 mV and 110 mV) and mature (APA above 110 mV) neurons and observed Ctrl-7 neurons separating into immature, intermediate and mature neurons. In contrast, NRXN1-a del neurons were observed only in immature neurons, intermediate mature neurons and no mature neurons (Fig. 4K, L and 4 M) . Similarly, when we looked at timing of action potential profile across patched neurons, we observed a clear yet non-significant trend relation between maturation properties by amplitude height and speed of action potential peak time ( Fig 4N) .
Our observations of depressed calcium signaling capacity, lower levels of neurotransmitter detected and emergence of maturation impairment in NRXN1-a del neurons indicate proof of dysfunction present and detectable in our NRXN1-a deletion ASD disease model.
As we identified functional differences in the potential for calcium signaling in NRXN1-a del neurons, we thought of analyzing other candidate genes with known cell adhesive function (CHL1, CNTN4, CNTN6, NLGN1) and described as contributing to disease burden of ASD [35] . We used the STRING database [36] and looked for NRXN1 interaction and found evidence for co-expression and interaction in other model organism, thus indicating evolutionary conserved function and mechanism between NRXN1 and the other candidate genes (Fig.  S4B) . We probed single cell transcriptome and bulk samples and found no CHL1 and CNTN4 expression in NRXN1-a del NES or DIFF cells (Figs. S4C-S4D) and confirmed protein absence of CHL1 in NRXN1-a del cells during neuronal differentiation (Fig. S4E) .
These observations suggest that NRXN1-a holds a key role for neuronal maturation and proposes deletion of NRXN1-a lead to skewed differentiation of NES cells into immature and inhibitory neurons as opposed to mature, functional inhibitory neurons and excitatory neurons during healthy neurogenesis.
Discussion
In the current study, we characterized the cellular properties of NES cells and neuronal cells from an individual with autism spectrum disorder carrying a bi-allelic NRXN1-alpha deletion. As a synaptic adhesion molecule, NRXN1 has been extensively investigated in interesting studies of synaptic transmission and neurotransmitter release in late stages of human neurogenesis [5, 37] . Here, we propose a novel role for NRXN1-a during early neurogenesis that affects cell identity of NES cells and alters outcome in character and maturation of differentiated neuronal cells.
In our study, we observed two waves of NRXN1 expression during neurogenesis, first during neural induction of iPS cells (Fig. 1B) and second during neuronal differentiation ( Fig. 1E and F) . In addition to differences in NRXN1-a expression between Ctrl-7 and NRXN1-a del cells, we observed, NRXN1-a del NES cells having a significantly lower proliferation capability, expressing radial glia-like genes and preferentially differentiating to astroglia (Figs. 1D, 2I and 2L and 3) . These observations align with previous description of mammalian radial glia cells transforming into astrocytes [38] . Our results suggest NRXN1-a holds functional role during neural induction and during the establishment of neural stem cells.
When we looked at neuronal cell adhesion molecules implicated in ASD and interactors of NRXN1 [35] (CNTN4, CNTN6, NLGN1, CHL1) ( Fig. S4B) we observed comparable gene expression profiles in Cortecon [25] displaying peaks during neural induction (Fig. S4F ). This suggests NRXN1 form cell-to-cell adhesion complexes transiently during neural induction to achieve close proximity between cells, possibly for enhanced signaling and structural integrity for establishment of structures like the neural rosette during in vitro induction culture. The enhanced cell-cell adhesion in the neural rosette mimics tight junctions of the developing neural tube during embryogenesis and the stem cell niche of the ventricular zone in developing brain and likely plays an essential part in providing a structurally supportive environment for efficient establishment and maintenance of neural stem cells.
Additionally, when looking at NRXN1 expression in human preimplantation embryonic cells [26] we found NRXN1 co-expressed with known interactors during early embryonic development (Fig. S4G) . These cumulative observations suggest NRXN1 presence not only in the synapse but also play an important part for the proper formation of the embryo, during early embryogenesis. Similarly, when we looked for NRXN1 expression in spatial transcriptomics data of early mouse 7.5 embryo (http://www.picb.ac.cn/hanlab/itranscriptome) [39] and during the early Xenopus developmental stages in single cell RNA-seq data (https://kleintools.hms.harvard.edu/tools/currentDatasetsList_ xenopus_v2.html) [40] we observed NRXN1 expressed during late gastrulation along the primitive streak in the mouse embryo and during early neurulation in early Xenopus developmental stages. These observations explain our result of finding NRXN1-a expression during neural induction and link NRXN1 to acting as an evolutionary conserved molecule (Fig. 1B) .
Focusing on neuronal differentiation of NRXN1-a del DIFF cells, we saw absence of NRXN1-a suspends neuronal maturation and appear to support generation of excitatory neurons (Fig. 4G ). Neurexin and neuroligin adhesion in Xenopus, a well-known neuronal maturation process resulting in dendritogenesis and synaptic maturation [41] together with action of Nrxn1 adding strength to synaptic glutamatergic transmission in mouse [42] suggests conserved functionality for NRNX1-a in supporting maturation of neuronal cells and in our study specifically suggests excitatory neuronal cells.
Our functional Ca 2+ signaling assay demonstrated significantly smaller Ca 2+ amplitudes and slower rise time kinetics in the NRXN1-a del DIFF cells (Fig. 4H -I and supporting movie 1) suggesting the depression (or absence) of expression of electrically excitable ion channels that are hallmarks of differentiated/mature neurons (i.e. voltage dependent Ca 2+ channels, Na+/K+ voltage dependent channels, and transporters/exchangers). Despite higher abundance of non-neuronal NRXN1-a del DIFF cells (50% of the cells), the wide spread depression in the rise time kinetics of the calcium amplitude seen in all NRXN1-a del DIFF cells, suggests disruption in Ca 2+ signaling being a direct result of NRXN1-a deficiency in both neuronal and non-neuronal cells. These observations link support to our observation of NRXN1-a del DIFF cells not maturing and remain immature, thus becoming predominantly immature neurons (Figs. 3D, 4I and 4K, 4L and 4 M).
Supplementary video related to this article can be found at https:// doi.org/10.1016/j.yexcr.2019.06.014. Our observations are consistent with studies where pan-neurexin deletion in mouse displayed decreased Ca 2+ -triggered neurotransmitter release and decreased action-potential evoked presynaptic Ca 2+ transients [12, 14] , aiding explanation to our NRXN1-a deletion ASD disease model is indeed recapitulating neuronal dysfunction. Validation of our ASD disease model is supported by two recent high impact studies reporting synaptic gene dys-regulation and astroglial gene up-regulation in postmortem ASD cerebral cortex [43, 44] . Others working with human iPS derived ASD neuronal cells have reported observations similar to ours with enrichment of astroglia, dysregulated calcium activity and hypoexcitability in neurons [45, 46] .
To address limitations, we make note that our observations come from disease modeling one very rare individual carrying a complete biallelic NRXN-a deletion of NRXN1-a. Herein also lay our strength in the ability of precisely study the effects of a complete deletion of NRXN1-a.
Taken together, our results suggest cell properties of healthy control neural stem cells and neurons stand in stark contrast to cell properties of neural stem cells and neurons with a complete deletion of NRXN1-a.
In conclusion, we propose NRXN1-a plays a pivotal role in the establishment of functionally efficient neural stem cells and NRXN1-a contributes to functional property and maturation in neurons. Fig. 4 . NRXN1-a deletion affects neuronal maturation and impairs emergence of excitatory neurons. A) TSNE plot highlights immature neuron and neuron cell type. B) TSNE plot highlights three neuronal cell subtypes (immature, excitatory and inhibitory neurons). C) Pseudotime ordering trajectory of immature and neuronal cell subtype. D) Trajectory of neuronal cell subtype, immature neuron excitatory and inhibitory neuron. E) Heatmap of branched gene expression over pseudotime, showing selected branch enriched genes, identifying immature neuron, inhibitory neuron and excitatory neuron expression profiles. F) Trajectory plots separated by individual, showing neuronal cell subtype aggregation along branches. G) Bar plots showing cell count and percentage of cell condition per individual, Ctrl-7 cells are aggregated along inhibitory and excitatory neuron branches, NRXN1-a del cells are aggregated mostly to immature and inhibitory neuron branches. H) Comparison of the Ca 2+ amplitudes to depolarizing concentrations of KCl (10 mM) between Ctrl-7 28d DIFF (n = 405, N = 3) and NRXN1-a 28d DIFF (n = 307, N = 3) cells and for Ctrl-7 49d DIFF (n = 180, N = 2) and NRXN1-a 49d DIFF (n = 202, N = 2). P-value < 0.001. I) Rise time kinetics of the Ca 2+ signal (20-80%) for Ctrl-7 28d DIFF (n = 405, N = 3) and NRXN1-a 28d DIFF (n = 307, N = 3) and of the Ca 2+ signal (0.05-100%) for Ctrl-7 49d DIFF (n = 180, N = 2) and NRXN1-a 49d DIFF (n = 202, N = 2). *** = P-value < 0.001. J) Representative Ca 2+ traces to depolarizing concentrations of KCl (10 mM), showing significantly smaller amplitudes (H) and slower rise time (I) in NRXN1-a DIFF compared to Ctrl-7 DIFF. Traces represent the mean of Ctrl-7 DIFF (n = 118, N = 1) and NRXN1-a DIFF (n = 79, N = 1) cells. K) Responsive patched cells acquired at 70-75 days of differentiation, cells classified with threshold set for maturity at action potential amplitude, below 95 mV Ctrl-7 immature neurons and NRXN1-a del immature neurons, between 95mV and 110mV Ctrl-7 intermediate neurons and NRXN1-a del intermediate mature neurons and above 110 mV Ctrl-7 mature neurons, no NRXN1-a del neurons reached above 110 mV at sampled 70-75 day time point. L) Representative action potential traces neurons differentiated for 70-75 days. Current injection (95 pA) invoked action potential and peak time (~7-12msec) in both Ctrl-7 neurons and NRXN1-a del neurons. Amplitude in Ctrl-7 mature neuron was consistently higher when compared to amplitude in NRXN1-a del intermediate mature neuron. Horizontal grid lines show beginning and peak of action potential for Ctrl-7 neuron, vertical grid line shows action potential reaching threshold at −20mV. M) Action potential amplitude was used to classify maturity, paired and unpaired t-test showed significant differences between all maturation stages both internally between all stages of Ctrl-7 neurons and NRXN1-a del neurons and across mature Ctrl-7 neurons and intermediate mature NRXN1-a del neurons, * = P-Value < 0.05. N) Action potential peaking times across maturation stages show a clear trend in low action potential amplitude corresponding slow action potential peak time. Largest difference seen between mature Ctrl-7 neurons and immature NRXN1-a del neurons (non-significant P-Value = 0.0562).
